Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type II; Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01477957
What this trial is testing

The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism

Who this might be right for
ObesityDiabetes Mellitus, Type 2
German Diabetes Center 450
Not applicableStudy completedNCT04264572
What this trial is testing

Project MiNT: Assessing the Impact of Food & Video-Based Nutrition Education on Patients With Poorly Controlled Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Thomas Jefferson University 600
Large-scale testing (Phase 3)Active Not RecruitingNCT06987695
What this trial is testing

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease

Who this might be right for
Obesity Disease
Amgen 279
Not applicableStudy completedNCT02711839
What this trial is testing

Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions

Who this might be right for
Type 2 Diabetes
Taipei Medical University 54
Not applicableStudy completedNCT02996539
What this trial is testing

Heart Rate Variability and Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients

Who this might be right for
Type2 Diabetes Mellitus
Shi wei, MM 392
Testing effectiveness (Phase 2)WithdrawnNCT03686657
What this trial is testing

Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients

Who this might be right for
Type 2 DiabetesHigh Blood PressureArthritis+1 more
ARKAY Therapeutics
Not applicableUnknownNCT04517201
What this trial is testing

AI-Assisted Insulin Titration System on Inpatients Glucose Control

Who this might be right for
Type 2 Diabetes
Shanghai Zhongshan Hospital 120
Early research (Phase 1)UnknownNCT03848637
What this trial is testing

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

Who this might be right for
Type 2 Diabetes Mellitus
Chong Kun Dang Pharmaceutical 28
Large-scale testing (Phase 3)Study completedNCT02926937
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 399
Post-approval studies (Phase 4)UnknownNCT05037695
What this trial is testing

SGLT-2 Inhibitors in Prevention of Post-procedural Renal and Cardiovascular Complications aFter PCI Among Patients With Diabetes Mellitus and Coronary Artery Disease: a Prospective, Randomized, Pilot Study (SAFE-PCI)

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery DiseaseAcute Kidney Injury
University of Sao Paulo General Hospital 40
Large-scale testing (Phase 3)Study completedNCT01072331
What this trial is testing

Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 99
Large-scale testing (Phase 3)Study completedNCT00976937
What this trial is testing

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 319
Post-approval studies (Phase 4)Study completedNCT00442845
What this trial is testing

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2,080
Large-scale testing (Phase 3)Study completedNCT01497522
What this trial is testing

Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 183
Not applicableStudy completedNCT05173675
What this trial is testing

Empathy in Action: Sunshine Calls for Life With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2DiabetesMental Health+1 more
University of Texas at Austin 260
Large-scale testing (Phase 3)Study completedNCT00162240
What this trial is testing

PPAR - Combination With Metformin

Who this might be right for
Diabetes Mellitus
Bristol-Myers Squibb 534
Not applicableStudy completedNCT02754817
What this trial is testing

The Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 611
Large-scale testing (Phase 3)Study completedNCT00111540
What this trial is testing

Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 456
Not applicableStudy completedNCT02800668
What this trial is testing

Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusObesity
Ruhr University of Bochum 19
Not applicableUnknownNCT01084850
What this trial is testing

Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal Subjects

Who this might be right for
Corneal Dystrophy
Frederiksberg University Hospital 300
Next Page